Healthcare -
Biotechnology - NASDAQ - US
$ 38.6444
-0.118 %
$ 10.8 B
Market Cap
21.96
P/E
EXEL - NET INCOME
Net Income EXEL - Exelixis, Inc.
521 M
LAST VALUE
69.11%
2 YEAR CAGR
10.18%
5 YEAR CAGR
14.70%
10 YEAR CAGR